References
Gallagher JJ. Tachycardia and cardiomyopathy: The chicken-egg dilemma revisited. JAm Coll Cardiol 1985;6:1172–1173.
Fenelon G, Wijn W, Andries E, Brugada P.Tachycardiomyopathy: Mechanisms and clinical implications. PACE 1996;19:95–106.
Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM.Tachycardiainduced cardiomyopathy: A review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709–715.
Schumacher B, Lüderitz B. Rate issues in atrial fibrillation:Consequences of tachycardia and therapy for rate control. Am J Cardiol 1998;82:29N–36N.
Redfield MM, Kay GN, Jenkins LS, Mianulli M, Jensen DN, Ellenbogen KA for the APT Investigators.Tachycardia-related cardiomyopathy: A common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc 2000;75:790–795.
Paelinck B, Vermeersch P, Stockman D, Convens C, Vaerenberg M. Usefulness of low-dose dobutamine stress echocardiography in predicting recovery of poor left ventricular function in atrial fibrillation dilated cardiomyopathy. Am J Cardiol 1999;83:1668–1670.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schumacher, B., Lüderitz, B. Tachycardia-Related Cardiomyopathy in Patients with Atrial Fibrillation. Card Electrophysiol Rev 5, 169–170 (2001). https://doi.org/10.1023/A:1011424631483
Issue Date:
DOI: https://doi.org/10.1023/A:1011424631483